Koshinski Asset Management’s Annovis Bio ANVS Stock Holding History

Koshinski Asset Management’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15,028	Closed	-$33.5K	–	770
2026 Q1	$33.5K	Buy	15,028 +18	+0.1%	+$49	﹤0.01%	727
2025 Q4	$51.9K	Buy	+15,010	New	+$45.1K	﹤0.01%	713
2023 Q4	–	Sell	-15,000	Closed	-$142K	–	508
2023 Q3	$142K	Hold	15,000	–	–	0.02%	545
2023 Q2	$214K	Hold	15,000	–	–	0.02%	542
2023 Q1	$231K	Buy	15,000 +5,000	+50%	+$80.7K	0.02%	495
2022 Q4	$134K	Hold	10,000	–	–	0.01%	579
2022 Q3	$137K	Hold	10,000	–	–	0.02%	522
2022 Q2	$113K	Buy	+10,000	New	+$109K	0.01%	577

Other funds holding ANVS

FNT

First National Trust Hermitage, Pennsylvania $2.95B AUM 27.19% 1-Year Est. Return

Sherry Group Mountain Home, Arkansas $102M AUM

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

SIAP

Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return

RSWM

Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return

QWM

Quadcap Wealth Management Frisco, Texas $1.03B AUM 28.22% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

WSFS

Wilmington Savings Fund Society Wilmington, Delaware $4.48B AUM 24.77% 1-Year Est. Return

GCM

Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

Koshinski Asset Management's ANVS Position: Q2 2026 in Review

Koshinski Asset Management sold out of Annovis Bio (ANVS) in Q2 2026, closing a stake of 15,028 shares — an estimated $33.5K sold.

Koshinski Asset Management first reported a position in ANVS in Q2 2022 and held it in 8 quarters. The position peaked at $231K in Q1 2023. 13 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

Koshinski Asset Management reported no remaining Annovis Bio position as of Q2 2026 after selling out during the quarter.
Koshinski Asset Management sold 15,028 Annovis Bio shares in Q2 2026, an estimated $33.5K.
Koshinski Asset Management first reported a position in Annovis Bio in Q2 2022 and held it in 8 quarters.
Koshinski Asset Management's Annovis Bio position peaked at $231K in Q1 2023.
13 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on Koshinski Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.